CSBR:NASDAQ
Champions Oncology Inc
US$4,70
0,00%
(0,00) 1D
13 ພ.ຈ., 15 ໂມງ 57 ນາທີ 39 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
65,49 ລ້ານ
Avg. vol.
8,15 ພັນ
Volume
244,00
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Mkt. cap
65,49 ລ້ານ
Avg. vol.
8,15 ພັນ
Volume
244,00
52-wk high
US$8,31
52-wk low
US$4,52
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
47 ນາທີກ່ອນ
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
53 ນາທີກ່ອນ
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
53 ນາທີກ່ອນ
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
2 ຊົ່ວໂມງກ່ອນ
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com